A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation




TekijätIftakhar-E-Khuda Imtiaz, Pessia Alberto, Zheng Shuyu, Kankainen Matti, Kontro Mika, Karikoski Marika, Laurila Juha, Gerke Heidi, Tadayon Sina, Hollmén Maija, Tang Jing, Imhof Beat A, Salmi Marko, Jalkanen Sirpa

Julkaisuvuosi2021

JournalCellular and Molecular Life Sciences

Tietokannassa oleva lehden nimiCellular and molecular life sciences : CMLS

Lehden akronyymiCell Mol Life Sci

Vuosikerta78

Aloitussivu7851

Lopetussivu7872

ISSN1420-682X

eISSN1420-9071

DOIhttps://doi.org/10.1007/s00018-021-03977-6

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/67815910


Tiivistelmä
Although the development of hematopoietic stem cells (HSC) has been studied in great detail, their heterogeneity and relationships to different cell lineages remain incompletely understood. Moreover, the role of Vascular Adhesion Protein-1 in bone marrow hematopoiesis has remained unknown. Here we show that VAP-1, an adhesin and a primary amine oxidase producing hydrogen peroxide, is expressed on a subset of human HSC and bone marrow vasculature forming a hematogenic niche. Bulk and single-cell RNAseq analyses reveal that VAP-1+ HSC represent a transcriptionally unique small subset of differentiated and proliferating HSC, while VAP-1- HSC are the most primitive HSC. VAP-1 generated hydrogen peroxide acts via the p53 signaling pathway to regulate HSC proliferation. HSC expansion and differentiation into colony-forming units are enhanced by inhibition of VAP-1. Contribution of VAP-1 to HSC proliferation was confirmed with mice deficient of VAP-1, mice expressing mutated VAP-1 and using an enzyme inhibitor. In conclusion, VAP-1 expression allows the characterization and prospective isolation of a new subset of human HSC. Since VAP-1 serves as a check point-like inhibitor in HSC differentiation, the use of VAP-1 inhibitors enables the expansion of HSC.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:45